Research Article

Modeling Drug-Carrier Interaction in the Drug Release from Nanocarriers

Figure 4

The model fit to release data. (a) Telmisartan from MSNPs with different pore sizes [30]. (b) Synthetic retinoid Am80 from PEG-PBLA NPs with different amine additives [11]. (c) DS from PLNPs in the release medium of various ionic strengths [10]. (d) Estradiol from PLGA NPs [12]. (e) Savoxepine from PLA NPs of two different sizes [13]. (f) Steroids from various PLA/PLGA NPs (■: PLA Mw 14,000; ∆ PLA Mw 9,000; : PLGA Mw 13,000; ○: PLGA Mw 8,000). BDP release (●) from PLA NPs (Mw 14,000) is a control [9]. Solid lines represent the model prediction.
370308.fig.004a
(a)
370308.fig.004b
(b)
370308.fig.004c
(c)
370308.fig.004d
(d)
370308.fig.004e
(e)
370308.fig.004f
(f)